Purple Biotech Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -3.03 | -100% |
| P/S |
|
-31.39 | 33.77 | -192.97% |
|
|
| P/BV |
|
11.78 | 4.83 | 143.98% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-17.66 | -22.17 | -20.32% |
|
|
| Ev/S |
|
-428.42 | 22.57 | -1997.97% |
|
|
| Ev/FCF |
|
-20.27 | 68.76 | -129.49% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | 743.15 | -100% |
| ROE |
|
-58.12 | 9.61 | -704.65% |
|
|
| ROA |
|
-44.87 | 0.3443 | -13134.88% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
2184.62 | -25.17 | -8779.42% |
|
|
| ROCE |
|
-64.94 | 15.45 | -520.31% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0159 | -3.68 | -99.57% | -0.0229 | -30.65% |
| Nеt Debt/Ebitda |
|
0.6405 | -3.44 | -118.64% |
|
|
| Debt/Ratio |
|
0.0079 | 0.1986 | -96.01% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.0177 | 10.32 | -100.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-191 | -57.64 | 231.37% | ||
| Growth impulse Ebitda in 5 years |
|
192.43 | -90.94 | -311.6% | ||
| Growth impulse Net Income in 5 years |
|
225.9 | -97.8 | -330.98% | ||
| Growth impulse FCF in 5 years |
|
243.38 | -108.72 | -323.86% | ||
| Growth impulse EPS in 5 years |
|
-97.15 | -142.05 | -31.61% |
IP Score
3.82/10
